Behavior and Behavior Mechanisms

52 trials 22 recruiting

Filter these 52 trials by phase, country and sponsor.

Open in Search →

Randomized, placebo-controlled clinical trial to investigate the safety and efficacy of two dexamfetamine sulfate formulations in adults wit… Recruiting

2024-515395-12-00 Adults with ADHD and moderate to severe depression 4 2025-05-22
Interest of Oxytocin as an Adjuvant Treatment of Psycho-educational Measures in Challenging Behaviors in Children With Autism Spectrum Disor… Recruiting

2024-516306-28-00 Autism with Spectrum Disorders and Moderate to Severe I 10 2025-02-12
Advancing the quality of treatment and care for acute agitation in emergency psychiatry Recruiting

2023-510201-18-00 acute agitation 10 2024-12-27
LAMAinDiab - comparison of 2 pharmacological therapies (lisdexamphetamine vs methylphenidate) for pediatric patients with ADHD and type 1 di… Recruiting

2023-506862-30-00 Attention-deficit hyperactivity disorder 4 2024-11-24
Cytisine for nicotine-containing electronic cigarette and tobacco cigarette cessation: a randomized placebo-controlled trial Recruiting

2023-504708-27-00 electronic cigarette cessation 5 2024-11-02
Evaluation of the effectiveness of hormonal treatment in adolescents suffering from gender dysphoria Recruiting

2024-513250-30-00 gender dysphoria 5 2024-06-25
Enhancing social attunement in autism via interpersonal sensorimotor synchronization therapy combined with single-dose intranasal oxytocin a… Recruiting

2023-505253-41-01 Autism Spectrum Disorder (ASD) 5 2024-06-18
Psilocybin for hospitalized patients with treatment-resistant depression Recruiting

2022-501857-35-00 treatment-resistant depression 4 2024-04-22
Evaluation of the effectiveness of the reconsolidation therapy in a clinical population suffering from post-traumatic stress disorder Recruiting

2022-500870-32-02 Post-traumatic stress disorder 4 2023-10-04
Evaluation of oxytocin treatment in children with autism and intellectual disability’, Multiple-dose Oxytocine - ASD and Intellectual Disabi… Recruiting

2024-513436-14-00 Autism spectrum disorder (ASD) 11 2023-05-30
NAlmefene versus placebo in addition to treatment as usual on craving in Behavioural Addictions (NABAb) Recruiting

2022-500085-96-00 Patients with gambling disorder or sexual addiction or 5 2023-03-31
Single dose pharmacokinetics of selective serotonin reuptake inhibitor sertraline in plasma of female anorexia nervosa patients and healthy… Recruiting

2024-512830-13-00 anorexia nervosa 3 2019-03-25
An open-label, randomized, single-dose, three-way crossover trial to evaluate the pharmacokinetics of nicotine pouch (NP) dry 4 mg compared … Ended

2025-523879-34-00 Nicotine use 2 2025-11-17
Morphine effects on stress response and social interaction – an exploratory randomized controlled experimental medicine study Ended

2024-517855-10-00 Healthy volunteers 4 2022-04-20
A global study to assess the effects of Osimertinib following chemoradiation in patients with Stage III unresectable non-small cell lung can… Ended

2022-500860-36-00 Histologically documented non-small cell lung cancer of 5 2018-09-19
Use of electronic cigarettes for smoking cessation Halted

2024-518135-10-00 Smokers smoking at least 10 cigarettes/day in the past 5 2024-10-31
Bioavailability study with naloxone hydrochloride in healthy volunteers Ended

2024-517838-17-00 No therapeutic indication in the current trial with hea 2 2026-03-06
Serotonin and decision-making Ended

2024-516055-41-00 None 6 2025-03-06
Clinical trial to compare availability in the body of the active substance nicotine as well as patch adhesion of the newly developed patch L… Ended

2023-503548-14-00 bioequivalence and patch adhesion trial; therapeutical 2 2024-09-30
Open label, single-center, two-part pharmacokinetic study: Part I: Relative bioavailability study to compare the pharmacokinetics of BP1.497… Ended

2024-512355-20-00 Binge eating disorder 3 2024-08-01
A study to test different doses of BI 1569912 in people with depression who take anti-depressive medicine Ended

2023-507942-10-00 Major depressive disorder 4 2024-07-31
Understanding the Neurobiology of Pharmacologically-induced Acute Stress on Ethical Decisions Ended

2023-508731-31-01 Mimic an acute stress response in humans. 6 2024-07-18
An Exploratory, Multicenter, Randomized, double-blind, placebo-controlled study evaluating the effect and safety of pitolisant in children a… Ended

2023-503678-18-00 Autism spectrum disorders 4 2023-10-10
Evaluation of the Effects of Neurexan® on Short-Term Insomnia, Daytime Performance and Stress Response by Polysomnography (PSG), Electroence… Ended

2024-514391-41-00 Short-Term Insomnia 4 2023-06-16